Čile -
španjolski -
ISPC (Instituto de Salud Pública de Chile)
sunitinib cápsulas 50 mg
logistics business services chile s.p.a. - sunitinib - sin formulas
Ekvador -
španjolski -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
sunitinib 25 mg
laboratorios biogenet scc ecuador - sunitinib 25 mg - capsula dura - cada cápsula contiene: sunitinib l-malato 33,4 mg (equivalente a 25,0 mg de sunitinib base)
Ekvador -
španjolski -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
sunitinib 50 mg
laboratorios biogenet scc ecuador - sunitinib l-malato 66,8 mg (equivalente a 50,0 mg de sunitinib base) - capsula dura - cada cápsula contiene: sunitinib l-malato 66,8 mg (equivalente a 50,0 mg de sunitinib base)
Ekvador -
španjolski -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
sunitinib 12,5 mg
laboratorios biogenet scc ecuador - sunitinib 12,5 mg - capsula dura - cada cápsula contiene: sunitinib l-malato 16,7 mg (equivalente a 12,5 mg de sunitinib base)
Ekvador -
španjolski -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
sunitinib 12,5 mg cápsulas
laboratorios stein s.a. costa rica - sunitinib 12,5 mg - capsulas - cada cápsula contiene: sunitinib 12.50 mg (equivalente a 16.7 mg de sunitinib malato)
Ekvador -
španjolski -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
sunitinib 25 mg cápsulas
laboratorios stein s.a. costa rica - sunitinib 25 mg - capsula - cada cápsula contiene: sunitinib 25.00 mg (equivalente a 33.4 mg de sunitinib malato)
Ekvador -
španjolski -
Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
sunitinib 50 mg cápsulas
laboratorios stein s.a. costa rica - sunitinib 50 mg - capsula - cada cápsula contiene: sunitinib 50.00 mg (equivalente a 66.8 mg de sunitinib malato)
Europska Unija -
španjolski -
EMA (European Medicines Agency)
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - agentes antineoplásicos - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
Čile -
španjolski -
ISPC (Instituto de Salud Pública de Chile)
gatrel cápsulas 12,5 mg (sunitinib)
synthon chile ltda. - sunitinib - sin formulas
Čile -
španjolski -
ISPC (Instituto de Salud Pública de Chile)
gatrel cápsulas 25 mg (sunitinib)
synthon chile ltda. - sunitinib - sin formulas